Global Ovulation Test Market Size Overview

• The Global Ovulation Test Market Size was worth around USD 2.48 Billion in 2023 and is predicted to Grow to around USD 3.57 Billion by 2033 with a compound annual growth rate (CAGR) of 3.71% between 2023 and 2033.
• The market for LH surge detection kits is being driven by the changing lifestyles and increasing reproductive age of women, as well as their preference for automated digital ovulation test kits.
• In addition, ovulation test use is expected to increase in many nations as a result of increased attention being paid to women's health.
• Additionally, the industry's possibilities are expanding as a result of major firms investing in R&D to reduce the cost of menstrual cycle tracking kits.

Major Vendors in the global ovulation test market

Accuquik Test Kits, Fairhaven Health LLC, Church & Dwight Co., Inc., Fertility Focus Limited, HiLin Life Products, Inc., Geratherm Medical AG, Nectar Lifesciences Ltd. (NLL), SPD Swiss Precision Diagnostics GmbH, Prestige Brands Holdings, and Others.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Decisions Advisors has segmented the ovulation test market based on the below-mentioned segments:

Global Ovulation Test Market, By Type

• Urine-based
• Saliva-based

Global Ovulation Test Market, By End User

• Hospitals
• Home Care Settings
• Clinics

Global Ovulation Test Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa